Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease

American Journal of Cardiology

Volumn 77, Issue 1, 1996, Pages 102-105

  Ivy, D Dunbar ^a,b   Kinsella, John P ^a   Wolfe, Robert R ^a   Abman, Steven H ^a  

^a Children's Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; AURICULIN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DRUG EFFECT; FEMALE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTRAARTERIAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0030034968     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89147-3     Document Type: Article

References (27)

1. Cartmill TB, DuShane JW, McGoon DC, Kirklin JW. Results of repair of ventricular septal defect. J Thorac Cardiovasc Surg 1966;52:486-501.
2. Clarkson PM, Neutze JM, Wardill JC, Barratt-Boyes BG. The pulmonary vascular bed in patients with complete transposition of the great arteries. Circulation 1976;53:539-543.
3. Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 1984;69:655-667.
4. Roberts J Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-453.
5. Ivy DD, Wiggins JW, Badesch DB, Kinsella JP, Kelminson LL, Abman SH. Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension. Am J Cardiol 1994;74:414-416.
6. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994;107:1129-1135.
7. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-820.
8. Kinsella JP, Toews WH, Henry D, Abman SH. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr 1993;122:803-806.
9. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88:2128-2138.
10. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994;108:487-494.
11. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
12. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 1990;86:1690-1697.
13. Adnot S, Andrivet P, Chabrier PE, Piquet J, Plas P, Braquet P, Roudot-Thoraval F, Brun-Buisson C. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest 1989;83:986-993.
14. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993;87:440-446.
15. Berner M, Beghetti M, Ricou B, Rouge JC, Pretre R, Friedli B. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993;19:75-77.
16. Foubert L, Latimer R, Oduro A, Gray S, Snow D, Wallwork J, Large S. Use of inhaled nitric oxide to reduce pulmonary hypertension after heart transplantation. J Cardiothorac Vase Anesth 1993;7:640-641.
17. Girard C, Lehot JJ, Pannetier JC, Filley S, French P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-883.
18. Haydar A, Malhere T, Mauriat P, Journois D, Pouard P, Denis N, Lefebvre D, Safran D, Vouhe P. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992;340:8834-8835.
19. Abman SH, Accurso FJ. Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. Am J Physiol 1991;260:H183-H192.
20. McQueston JA, Kinsella JP, Ivy DD, McMurtry IF, Abman SH. Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am J Physiol 1995;268:H288-H294.
21. Kikuchi K, Nishioka K, Ueda T, Shiomi M, Takahashi Y, Sugawara A, Nakao K, Imura H, Mori C, Mikawa H. Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases. J Pediatr 1987;111:335-342.
22. Matsuoka S, Kurahashi Y, Miki Y, Miyao M, Yamazaki Y, Nishiuchi T, Saito S. Plasma atrial natriuretic peptide in patients with congenital heart diseases. Pediatria 1988;82:639-643.
23. Adnot S, Chabrier PE, Andrivet P, Viossat I, Piquet J, Bran-Buisson C, Gutkowska Y, Braquet P. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis 1987;136:951-956.
24. Oberhansli I, Mermillod B, Favre H, Friedli B, Girardin E, Paunier L. Atrial natriuretic factor in patients with congenital heart disease: correlation with hemodynamic variables. J Am Coll Cardiol 1990;15:1438-1445.
25. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
26. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
27. Houde C, Bonn DJ, Freedom RM, Rabinovitch M. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J 1993;70:461-468.